ADVB · Advanced Biomed Inc.
Market Cap
$13.06M
Shares
1.38M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Yi Lu | Ph.D., Former Chairman & CEO | — |
| Mingze Yin | Director and Chief Financial Officer | — |
| Steven I-Fang Cheng | Ph.D., Former Chief Technology Officer | — |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Steven I-Fang Cheng | Ph.D., Former Chief Technology Officer | — |
| Mingze Yin | Director and Chief Financial Officer | — |
| Yi Lu | Ph.D., Former Chairman & CEO | — |
Key facts
CIK
1941029
CUSIP
00752P203
13F (30d)
2 filings
1 filers